As previously reported, BofA downgraded Navient (NAVI) to Underperform from Neutral with a price target of $12, down from $15. While the firm appreciates the company’s execution on cost cutting and business divestments, it views the “Phase 2” growth initiatives as more difficult than the “Phase 1” focus on expense reductions and capital allocation and believes a shift to growth has “significantly higher execution risk,” the analyst tells investors. Early indications suggest additional loan products, fee-based products, or leaning further into in-school lending are potential options, but all of these come with near-term risks, the analyst added.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NAVI:
- Navient downgraded to Underperform from Neutral at BofA
- Navient price target lowered to $12 from $13.50 at TD Cowen
- Navient price target lowered to $15 from $16.50 at Keefe Bruyette
- Navient Reports Mixed Q2 2025 Financial Results
- Navient’s Financial Challenges and Strategic Uncertainties Justify Sell Rating
